Frost Radar™: Clinical-Grade Wearables, 2024

Clinical-grade wearables are regulatory-approved devices that provide clinically actionable data for monitoring, diagnostic, and therapeutic applications. As demand for continuous remote monitoring of patients increases to mitigate healthcare challenges, such as rising costs and staff shortages, so will the potential for wearable devices to support remote care models, including home care and hospital-to-home initiatives.

Moving beyond standard consumer-centric applications, highly sophisticated clinical-grade wearables, such as patches and bands, collect crucial patient information, including cardiac and vital signs data, to aid early disease detection and timely intervention to enhance patient outcomes.

In a field of more than 40 clinical-grade wearables industry participants globally, this Frost Radar™ analysis highlights the top 13 companies that excelled in growth and the ability to drive visionary innovation between 2021 and 2023. These companies provide clinical-grade wearables with US FDA and EU CE clearance for continuous monitoring of heart rate and arrhythmias, and vital signs. Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™, considering their strengths and the opportunities that best fit those strengths.